Research and development (R&D) is one of the most challenging functions to transform. In life sciences, there is intense pressure on R&D to deliver better products cheaper, faster, and with less risk.
Thanks to Intelligent Industry, powered by data, Capgemini can help life sciences companies deepen and accelerate the value that R&D delivers.
Data-driven R&D transformation in life sciences
We can help you apply analytics across every aspect of data and information that you want to incorporate in your R&D.
In advanced pharmaceutical discovery and development, our data-driven approach will help you better understand diseases and patients, identify therapies with higher potential, and accelerate time to market of your development.
Give patients and payers what they really want
R&D teams can now access the entire body of clinical data and literature about drugs and conditions, and incorporate it into their processes in real time. And “real-world” data – medical data, insurance data, even social media – can provide valuable insights into patient needs, treatment adherence, and outcomes.
Our role is to use data-driven R&D techniques to augment the work you’re already doing and improve it with better access to, faster handling of, and deeper learning from – data.
We understand R&D culture because we’ve worked in it for decades. We inject our AI and data analytics techniques into your established R&D processes, adding cutting-edge innovations into proven methodologies.
We focus on your business outcomes first, helping you bring innovative products to market faster, with the lowest risk possible.
It’s another way the potential of Intelligent Industry, powered by data, is coming to life.